Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Eggshell extract promises youthful skin in new study

NCT ID NCT07188051

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This 12-week study tests whether a daily eggshell membrane supplement (Ovolux) can improve skin firmness and moisture in 100 healthy adults aged 35-65 with sagging or dry skin. Participants will take capsules and have their skin and hair measured with special devices. The goal is to see if the supplement supports beauty from within.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant is willing and able to read, understand, and provide written Informed Consent and Photo Release. * Participant is a healthy female or male, aged 35 through 65 years (inclusive). * Participant is willing and able to swallow capsules. * Participant has self-perceived facial wrinkles and facial sagging skin. * Participant is seeking improvements to hair and nails such as hair growth and thickness and nail strength and appearance. * Participant agrees to keep their hair at least 3 inches long. * Participant is willing to comply with all study procedures and attend all study visits. * Participant agrees not to have any hair cosmetic procedures such as relaxers or perms, etc. while on the study. Coloring/dyeing is permitted if part of the participant's regular routine and this routine is maintained during the study. * Participant is willing to forego taking any hair, nail or skin supplements or using/applying any other hair, nail or skin products on their hair/scalp, nails or face that promote nail or hair growth or are collagen boosting for the duration of the study. * Participant is willing to discontinue any hair or nail or collagen boosting dietary or nutritional supplements two weeks before the onset of the study and for the study duration. Dietary supplements such as a general multi-vitamin, vitamins A, C or D, iron or calcium are acceptable. * Participant agrees not to wet their face or consume hot or cold or caffeine containing foods or beverages within 2 hours of all visits. * Participant reviewed the ingredient list for the test article (dietary supplement) and the placebo and, to the best of their knowledge, confirmed they have no sensitivity or allergy to the ingredients. * Females of child bearing potential must agree to use an adequate method of birth control, which include: systemic birth control (must have been on the same type of systemic birth control for at least 3 months prior starting the study and must not change the type of birth control during the study); diaphragm with spermicide, condom with spermicide; IUD (hormonal or copper); Vasectomized partner; bilateral tubal ligation; or Abstinence. Females who are post-menopausal (absence of menses for at least 1 year), have had a hysterectomy or have had a bilateral oophorectomy do not need any additional birth control are considered to be not of childbearing potential; (Confirmed by verbal response only). Exclusion Criteria: * Participant is allergic to eggs or egg proteins. * Participant is a smoker. * Participant has a current skin disease on or near the scalp (e.g., eczema, psoriasis) or anywhere else on the body. * Participant has any allergies or sensitivities to any dietary or nutritional supplements or their ingredients. * Participant has artificial nails (press-on, glue-on, gel, acrylic, etc.). Nail polish is permitted if part of regular nail routine and if this routine is maintained during the study. * Participation in another supplement study in the past 30 days. * Participant has dreads or weaves. * Participant has had any chemical hair procedure (used relaxers, perms, etc.) in the last 8 weeks. * Participant has dyed their hair within the last 3 days. * Participant has a diagnosed hair loss disorder such as alopecia areata, scarring alopecia, and/or androgenetic alopecia and/or pattern baldness. * Participant is taking or using any medications or supplements (over the counter or prescription, topical or oral) for hair growth such as minoxidil, finasteride, dutasteride, spironolactone, collagen, amino acids, keratin, biotin, rosemary oil, corticosteroid injections, etc. or treatments for hair growth such as laser treatment or supplements for nails or skin. * Participant is under treatment by a medical professional for a hair/scalp, nail or skin condition. * Participant has any concomitant skin diseases of the scalp or skin such as atopic dermatitis, seborrheic dermatitis, psoriasis, eczema, tinea capitis, etc. or irritation such as rash, sores, etc. on the scalp. * Participant has an infestation on the scalp such as lice. * Female Only: Participant is pregnant, planning to become pregnant during the course of the study or nursing (self-reported). * Participant has been diagnosed with chronic skin allergies. * Current use of OTC pain medication ingested in quantities exceeding label use. * Participant has been diagnosed with any type of cancer especially skin cancer within the past 12 months or treated for cancer in the last 5 years. * Participant is routinely using any anti-inflammatories, and/or antihistamines. * Participant has a history of any chronic diseases such as insulin dependent diabetes, HIV/AIDS, etc. * Participant has any medical condition or is taking a medication that would compromise the safety of the participant or preclude participation in the study per the Principal Investigator. * Participant is currently participating in another clinical trial involving the skin, scalp or hair or nails.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin dryness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Princeton Consumer Research Corp.

    Cincinnati, Ohio, 45239, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.